Page last updated: 2024-11-06

prednisolone and Deficiency Disease, Ornithine Carbamoyltransferase

prednisolone has been researched along with Deficiency Disease, Ornithine Carbamoyltransferase in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"The prednisolone was stopped 5 days before hospital admission."1.72Late-Onset Ornithine Transcarbamylase Deficiency Complicated with Extremely High Serum Ammonia Level: Prompt Induction of Hemodialysis as the Key to Successful Treatment. ( Kakiuchi, T; Kurogi, K; Nishi, TM; Tago, M; Yamamoto, S; Yamashita, S; Yamashita, SI, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yamamoto, S1
Yamashita, S1
Kakiuchi, T1
Kurogi, K1
Nishi, TM1
Tago, M1
Yamashita, SI1

Other Studies

1 other study available for prednisolone and Deficiency Disease, Ornithine Carbamoyltransferase

ArticleYear
Late-Onset Ornithine Transcarbamylase Deficiency Complicated with Extremely High Serum Ammonia Level: Prompt Induction of Hemodialysis as the Key to Successful Treatment.
    The American journal of case reports, 2022, Nov-15, Volume: 23

    Topics: Adult; Ammonia; Child; Humans; Hyperammonemia; Infant; Male; Ornithine Carbamoyltransferase; Ornithi

2022